Ondine Biomedical, Inc.'s total assets for Q2 2024 were C$4.03M, a decrease of -29.80% from the previous quarter. GB:OBI total liabilities were C$4.01M for the fiscal quarter, a 9.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.